NMDA-IN-2

NMDA-IN-2 (compound 6b), a Procaine derivative, is a NMDA receptor 2B subtype inhibitor[1].

Product Specifications

CAS Number

2761731-14-8

UNSPSC

12352005

Target

IGluR

Type

Reference compound

Related Pathways

Membrane Transporter/Ion Channel; Neuronal Signaling

Applications

Neuroscience-Neurodegeneration

Field of Research

Neurological Disease

Assay Protocol

https://www.medchemexpress.com/nmda-in-2.html

Solubility

10 mM in DMSO

Smiles

CC1CN(CC(O1)C)CCOC(C2=CC=C(C=C2)N)=O

Molecular Formula

C15H22N2O3

Molecular Weight

278.35

References & Citations

[1]Yin J, et, al. Design, synthesis and biological evaluation of novel procaine derivatives for intravenous anesthesia. Bioorg Med Chem Lett. 2022 Mar 15;60:128587.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

NMDA Receptor

More Discoveries

Explore Other Products

Browse additional items from our catalog

OR1063001-01 5 mg

6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2 (3H) -one hydrochloride hydrate

View Details

OR1063001-02 25 mg

6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2 (3H) -one hydrochloride hydrate

View Details

OR1063001-03 100 mg

6,7-Dichloro-1,5-dihydroimidazo[2,1-b]quinazolin-2 (3H) -one hydrochloride hydrate

View Details

MBS1352621-01 0.02 mg (E-Coli)

Recombinant Neisseria meningitidis serogroup A / serotype 4A Chorismate synthase (aroC)

View Details

MBS1352621-02 0.02 mg (Yeast)

Recombinant Neisseria meningitidis serogroup A / serotype 4A Chorismate synthase (aroC)

View Details

MBS1352621-03 0.1 mg (E-Coli)

Recombinant Neisseria meningitidis serogroup A / serotype 4A Chorismate synthase (aroC)

View Details